CategoryMedical & Pharma
ASCO Annual Meeting
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to ASCO Annual Meeting — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
ASCO Annual Meeting (American Society of Clinical Oncology) — Event Research Description
What We Know From the Official Source Provided
- Official organization / event host: American Society of Clinical Oncology (ASCO)
- Dates / venue for “ASCO Annual Meeting”: Not present in the official website text you provided, so we cannot reliably state the annual meeting’s exact dates or location from this source.
Context: Why the ASCO Annual Meeting Matters in Oncology
The ASCO Annual Meeting is widely recognized as one of the highest-impact global gatherings for oncology research, clinical practice updates, and translational science. For sponsor/exhibitor audiences and B2B buyers, these meetings create a dense environment where decision-makers converge around: clinical innovation, late-stage research visibility, pipeline benchmarking, guideline-aligned education, real-world implementation needs, and commercial engagement with cancer care stakeholders.
Because the annual meeting’s exact dates and venue are not included in the text provided, we focus the analysis on attendee/buyer behavior, buyer fit, engagement themes, estimated audience dynamics, and the types of buyer organizations that typically align with ASCO-style programming.
Event Type Summary
- Industry / theme: Oncology, cancer research, clinical oncology practice, translational medicine, healthcare innovation
- Primary stakeholders: Biopharma, biotech, oncology-focused medtech, diagnostics, specialty healthcare services, research institutions, hospitals/health systems, academic oncology leaders, and clinical education stakeholders
- Event experience: Abstracts, presentations, guidelines, posters, and education-style content that draws both scientific and business-facing audiences
1️⃣ Who Attends (BUYERS / ATTENDEES)
The ASCO Annual Meeting attendee mix generally includes both clinical/scientific and commercial stakeholders. For our attendee-list research and buyer targeting, the most monetizable and “decisionable” attendee layers usually fall into the following categories:
- Clinical leaders and decision influencers (high-value for medical/clinical programs): medical oncologists, hematology-oncology physicians, oncology fellows, clinical researchers, and practice leaders
- Academic and research stakeholders: university research faculty, translational medicine teams, clinical trial operations leaders, and oncology research administrators
- Biopharma and biotech business stakeholders (top buyer fit): medical affairs leaders, clinical operations leads, market access, oncology specialty marketing leadership, HEOR/insights, and oncology business development
- Diagnostics and medtech business stakeholders: clinical evidence/real-world data leads, product strategy leaders, clinical development, and commercialization leadership
- Specialty pharmacy / access ecosystem (strong buyer fit): patient services leadership, reimbursement/access leaders, and program operations managers
- Healthcare systems and provider organizations: oncology program directors, pharmacy directors, value-based care leadership, and network development teams
Best “Buyer-Style” Attendee Roles We Typically Target
- Vice President / Director of Oncology Medical Affairs
- Director, Clinical Operations (Oncology Trials)
- Director, Market Access / HEOR (Oncology)
- Oncology Marketing Director / Product Marketing Lead (Specialty)
- Senior Manager, Patient Support / Access Programs
- Director, Clinical Evidence / Real-World Evidence (RWE)
- Director, Research Partnerships / Business Development (Oncology)
- Head of Oncology Portfolio Strategy
2️⃣ Where the Show Is Happening + Attendee Geographic Origin
From the official text provided, the only explicitly listed “meeting” location is for an ASCO Quality Care Symposium (Oct 16–Oct 18, 2026 in Boston, MA & Online), not for the ASCO Annual Meeting. Since the annual meeting’s venue/city/country are not stated in the text you provided, we do not fill those fields with guesses.
What We Can Reliably Describe About Geographic Origin (Without Inventing Annual Meeting Details)
- Primary global origin profile: international oncology communities attract worldwide participants because oncology R&D, clinical trials, and market access strategies are globally interconnected.
- Expected strongest concentration: North America and large Western Europe cohorts are typically the most visible segments in ASCO-style events, with meaningful representation from Asia-Pacific and other regions.
How We Recommend We Target Geography in Buyer Research
- Buyer HQ targeting: United States + major biopharma hubs globally (to capture commercial/medical affairs leaders)
- Trial network targeting: countries with active oncology trials and large academic centers
- Regional oncology specialty clusters: providers and networks that run oncology programs and patient services
3️⃣ Audience Reach (Local / National / Global)
For our planning and buyer-fit analysis, the ASCO Annual Meeting audience is best treated as global in reach even if the event venue is specific to a host city. The content themes—clinical oncology, research, and evidence—carry international relevance for R&D, clinical trial strategy, and market access.
- Reach classification: Global (with heavy North America relevance)
- Commercial impact: multinational biopharma/biotech and global medtech/diagnostics teams align their evidence and pipeline messaging with ASCO moments
4️⃣ Sample Buyer Company Names (BUYERS ONLY) + Websites
Below is a sample of buyer organizations that strongly align with oncology research visibility, medical affairs engagement, clinical evidence, and commercialization needs. These are “buyer-fit” targets for attendee-list research and sponsorship-style outreach positioning. (We still recommend validating each company’s exact participation for the specific annual meeting year when we finalize the list.)
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Roche | https://www.roche.com | Director, Oncology Medical Affairs / Clinical Evidence Lead | Strong oncology portfolio; engages deeply with clinical evidence, trial outputs, and medical education ecosystems. |
| 2 | Novartis | https://www.novartis.com | Head of Oncology Medical Affairs / Market Access Oncology | Oncology-focused strategy and global market access priorities that align with ASCO presentations and guideline-driven education. |
| 3 | Pfizer | https://www.pfizer.com | Senior Director, Oncology Clinical Development / Clinical Operations | Oncology pipeline and trial operations teams require high-density access to clinical researchers and practice leaders. |
| 4 | Merck & Co. (MSD) | https://www.merck.com | Director, Oncology Medical Affairs / Evidence Generation Lead | Medical affairs and evidence generation are central for oncology brand positioning and education programs. |
| 5 | Bristol Myers Squibb | https://www.bms.com | Oncology Product Marketing Director / Portfolio Strategy Lead | Specialty oncology commercialization teams benefit from ASCO’s concentration of oncology decision influencers. |
| 6 | AstraZeneca | https://www.astrazeneca.com | Director, Oncology Market Access / HEOR Lead | Value and access positioning require evidence dissemination and stakeholder engagement. |
| 7 | Amgen | https://www.amgen.com | Director, Oncology Medical Affairs / Clinical Evidence & RWE | Oncology leadership teams use conferences to coordinate evidence narratives and connect with clinical ecosystems. |
| 8 | Gilead Sciences | https://www.gilead.com | Senior Director, Oncology Clinical Development (where applicable) / Clinical Trials Ops | Oncology-adjacent research and clinical development teams align with large-scale clinical meeting dynamics. |
| 9 | Sanofi | https://www.sanofi.com | Director, Oncology Medical Affairs / Research Partnerships Lead | Medical affairs and partnerships rely on meeting-driven visibility and stakeholder mapping. |
| 10 | Bayer | https://www.bayer.com | Director, Oncology Clinical Evidence / Market Access Strategy | Oncology-related strategy benefits from ASCO-aligned evidence and decision-maker concentration. |
| 11 | AbbVie | https://www.abbvie.com | Oncology Medical Affairs Director / Clinical Development Program Lead | Oncology programs require medical education, evidence sharing, and stakeholder engagement. |
| 12 | IQVIA | https://www.iqvia.com | Senior Manager, Oncology Insights / HEOR & Real-World Evidence | Market insights and evidence analytics teams can leverage ASCO audiences for partnerships and data programs. |
| 13 | Cancer Research UK (buyer fit for partnerships/education) | https://www.cancerresearchuk.org | Director, Clinical Trials Partnerships / Research Strategy Lead | Research and trials partnership leaders align with ASCO’s translational oncology ecosystem. |
| 14 | Caris Life Sciences | https://www.carislifesciences.com | Director, Clinical Evidence / Diagnostics Partnerships | Precision oncology diagnostics teams benefit from oncology evidence conversations and physician-influencer ecosystems. |
| 15 | Guardant Health | https://www.guardanthealth.com | Head of Clinical Evidence / Director, Oncology Partnerships | Liquid biopsy leadership needs high-quality stakeholder alignment for clinical evidence and partner programs. |
| 16 | Foundation Medicine | https://www.foundationmedicine.com | Director, Clinical Evidence / Market Development (Oncology) | Genomic profiling organizations align well with oncology decision-maker attention and evidence-driven engagement. |
| 17 | Specialty Pharmacy Provider (example buyer type) | https://www.ashfieldhealth.com (category example; confirm target during list finalization) | Director, Patient Support Programs / Access Operations | Patient support and adherence program leadership are strongly tied to oncology care pathways. |
| 18 | Medtronic (oncology-adjacent where applicable) | https://www.medtronic.com | Director, Clinical Evidence / Oncology Segment Strategy | For oncology-adjacent clinical workflows, evidence and stakeholder mapping are key conference objectives. |
| 19 | Thermo Fisher Scientific | https://www.thermofisher.com | Director, Clinical Research Solutions / Oncology Lab Partnerships | Clinical research and laboratory solution teams benefit from dense academic and industry oncology presence. |
| 20 | Syneos Health | https://www.syneoshealth.com | Director, Oncology Clinical Operations / Business Development | Clinical operations and commercialization support teams align with oncology trial and evidence cycles. |
Top 5 “Send First” Buyer Targets (Buyer-Fit Shortlist)
- Roche
- Novartis
- Pfizer
- Merck & Co. (MSD)
- Bristol Myers Squibb
5️⃣ Job Profiles, Industries & Event Type
Job Profiles to Target (Apollo-style roles, written as job titles for our workflow)
- Director / VP, Oncology Medical Affairs
- Director, Clinical Operations (Oncology)
- Clinical Development Program Lead, Oncology
- Director, Market Access / HEOR (Oncology)
- Evidence Generation Lead (RWE / Clinical Evidence)
- Oncology Product Marketing Director
- Director, Oncology Business Development / Partnerships
- Patient Support Program Director / Specialty Patient Services Lead
- Research Partnerships Director (Academic-Industry partnerships)
Industries We Map From the Provided Industry List
Based on ASCO’s oncology focus, the most relevant industries from your provided industry taxonomy are:
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Hospital & Health Care
- Medical Practice
- Research
- Program Development
- Professional Training & Coaching (for education modules, training, and clinical education vendors)
- Market Research (for insights/HEOR/evidence teams)
- Marketing & Advertising (for oncology marketing and evidence messaging)
- Information Services (for clinical information, evidence platforms, analytics)
- Staffing & Recruiting (only for clinical operations/research staffing partners—used selectively)
Event Type (How We Classify for Buyer Engagement)
- Scientific & clinical congress
- Healthcare innovation / education conference
- Clinical research & translational medicine meeting
- Commercial engagement ecosystem (medical affairs, market access, evidence generation, specialty marketing)
6️⃣ Estimated Attendance (Expected Total Footfall)
The official text you provided does not include ASCO Annual Meeting attendance numbers. Therefore, we cannot reliably state an “expected total footfall” for the annual meeting based on this source alone.
If you share the official annual meeting page URL (or the text for “attendance” / “number of participants”), we can compute and format an accurate attendance estimate in the same structure we used for other events.
7️⃣ Key Focus Areas & Buyer Engagement
Key focus areas (what buyers want to influence)
- Evidence dissemination: how new trial results translate into clinical practice
- Guideline-aligned education: mechanisms that help clinicians and institutions adopt best practices
- Clinical trial visibility: where pipeline updates attract partnerships and trial referrals
- Market access and reimbursement alignment: outcomes frameworks, HEOR narratives, and value story mapping
- Patient pathways support: patient services, adherence, and specialty access programs
- Translational innovation: lab-to-clinic progress and biomarker-driven approaches
How buyers typically engage at this type of meeting
- Medical affairs sponsorships, investigator meetings, and evidence-focused education sessions
- Clinical operations networking with research sites, trial coordinators, and academic investigators
- Partnership outreach between diagnostics/genomics providers and clinical programs
- Commercial discussions through oncology ecosystem stakeholders (provider systems, specialty pharmacy ecosystems, market access groups)
8️⃣ Client-Product Fit: We Need Your Website to Select the Best Buyer Organizations
For step 8, we follow a strict product-to-buyer matching approach. To identify the best buyers for your client’s specific needs, please share: the client product website URL (and if available, the product one-liner / target customer).
Once we have that, we will tailor the buyer list to match what your client sells, for example:
- If your client sells oncology clinical education, CME-style training, or guideline support: we will prioritize medical education and medical affairs decision-makers.
- If your client sells diagnostics/genomic testing platforms: we will prioritize clinical evidence leads and diagnostics partnership decision-makers.
- If your client sells specialty patient support / access services: we will prioritize patient services and reimbursement/access program leaders.
- If your client sells clinical research services (CRO-like offerings) or trial tooling: we will prioritize clinical operations and research partnerships decision-makers.
Please send the client website and we will return the optimized “best buyer” cohort aligned to your requirements.
9️⃣ Final Recommendation (Buyer Quality & Targeting Strategy)
- Why this event is a strong research target: it concentrates oncology decision influencers, evidence stakeholders, and commercial oncology leadership across pharma/biotech, diagnostics, and clinical ecosystems.
- Best buyer strategy: prioritize medical affairs, clinical operations, market access/HEOR, evidence/RWE, oncology marketing, and oncology partnerships.
- Quality scoring (relative, since attendance/venue specifics are not provided here): High fit for oncology commercialization + evidence engagement buyers, and high relevance for clinical education and research partnership providers.
Quick Next Step We Need From You
- Share the client website URL so we can identify the best buyer organizations aligned to your client requirements.
- If you want exact ASCO Annual Meeting date/venue, share the official annual meeting page text or URL that includes “meeting date” and “location”.
Data sheet
ASCO Annual Meeting – Event Attendee & Buyer Profile Analysis
Event Date: 2026-05-29 to 2026-06-02
Location: Chicago, United States
Event Status: Upcoming
Research Date: 2026-07-06
Event Overview
| Event Name | ASCO Annual Meeting |
| Event Date | 2026-05-29 to 2026-06-02 |
| Event Status | Upcoming |
| Venue | Not publicly confirmed in the provided official text |
| City | Chicago |
| State / Region | Not confirmed in the provided official text |
| Country | United States |
| Organizer | American Society of Clinical Oncology (ASCO) |
| Official Event Website | asco.org |
| Event Type | Scientific congress / medical association meeting / oncology education and research event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research, Business Services |
| Audience Reach | Global oncology audience with strong North American concentration |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low to Medium; current-year attendee count not publicly confirmed in the provided source |
| Main Purpose of Event | Dissemination of oncology research, clinical education, guideline updates, peer exchange, product visibility, partnership development, and healthcare decision-making |
About the Event
The ASCO Annual Meeting is one of the most influential global gatherings in oncology, bringing together clinicians, researchers, hospital leaders, pharmaceutical teams, biotech companies, and healthcare decision-makers. It serves as a major platform for late-breaking clinical data, treatment innovation, guideline-driven education, and the practical adoption of cancer care advances across the care continuum.
For commercial and B2B audiences, the meeting is important because it concentrates high-value stakeholders who influence therapy adoption, research collaboration, trial enrollment, technology procurement, service partnerships, and institutional purchasing. It is especially relevant to suppliers serving oncology practices, cancer centers, life sciences organizations, diagnostics, clinical trial infrastructure, digital health, and healthcare operations.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Oncology clinicians and department leaders | Cancer centers, hospitals, academic medical centers | Clinical decision influence, protocol adoption, tool evaluation | High relevance for diagnostics, devices, software, education, and workflow solutions |
| Procurement and sourcing teams | Health systems, group practices, cancer networks | Vendor selection, purchasing, contracting | Strong fit for clinical supply, technology, and outsourced services vendors |
| Pharma and biotech market access teams | Biopharma manufacturers, specialty pharma, biotech | Evidence generation, commercialization, education, partnerships | High relevance for data, real-world evidence, patient support, and congress services |
| Clinical trials and research operations teams | Trial sites, CROs, academic research institutions | Trial execution, vendor evaluation, patient recruitment, data systems | Strong fit for research technology, patient engagement, and site support vendors |
| Diagnostics and pathology leaders | Reference labs, hospital labs, molecular diagnostics providers | Assay adoption, workflow standardization, testing strategy | Highly relevant for lab instruments, reagents, informatics, and automation |
| Health IT and digital transformation leaders | Providers, payers, life sciences firms, digital health vendors | Technology evaluation, interoperability, analytics, AI governance | Relevant for data platforms, AI, EHR, CRM, and workflow software |
| Payer and reimbursement stakeholders | Commercial insurers, government payers, PBMs | Coverage policy, value assessment, utilization management | Relevant for HEOR, RWE, outcomes, and patient access solutions |
| Association, policy, and advocacy leaders | Professional associations, advocacy groups, public health bodies | Policy influence, education, coalition building | Useful for sponsorship, awareness, education, and public affairs outreach |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Chicago | Local attendees, regional executives, meeting staff, and nearby medical centers | High | Large healthcare and life sciences corridor with easy domestic access |
| Host state / region | Midwest hospitals, academic centers, payers, and suppliers | High | Strong concentration of healthcare systems and medical research institutions |
| Nearby business hubs | New York, Boston, Philadelphia, Washington DC, Minneapolis, St. Louis, Indianapolis | High | Short-haul domestic travel makes attendance practical for enterprise buyers |
| National reach | US oncology community, hospitals, payers, pharma, biotech, CROs | Very High | ASCO is a national priority event for healthcare commercialization and research networking |
| International reach | Canada, Europe, Asia-Pacific, Latin America, Middle East, Africa | Very High | Global oncology stakeholders often attend for science, partnerships, and commercialization |
| Relevant trade corridor | US life sciences, diagnostics, and health system procurement corridors | High | Ideal for supplier targeting across the clinical and commercial oncology ecosystem |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | ASCO is a globally recognized oncology meeting drawing international scientific, clinical, and commercial participation. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| MD Anderson Cancer Center | Cancer center / provider | Large oncology buyer for clinical systems, diagnostics, research support, and enterprise services | mdanderson.org | Chief Medical Officer, Oncology Director, Procurement Director, IT Director | Strong Market Fit, Attendance Not Confirmed |
| Memorial Sloan Kettering Cancer Center | Cancer center / provider | High-value oncology institution with demand for clinical, research, and digital solutions | mskcc.org | VP Clinical Operations, Director of Sourcing, Research Administration Lead | Strong Market Fit, Attendance Not Confirmed |
| Mayo Clinic | Health system / provider | Enterprise buyer for oncology care delivery, analytics, education, and research infrastructure | mayoclinic.org | Procurement Manager, Clinical Informatics Director, Cancer Center Administrator | Strong Market Fit, Attendance Not Confirmed |
| Cleveland Clinic | Health system / provider | Large integrated system with oncology operations, digital, procurement, and education needs | clevelandclinic.org | Director of Procurement, VP Oncology, Supply Chain Leader, Digital Health Director | Strong Market Fit, Attendance Not Confirmed |
| Dana-Farber Cancer Institute | Cancer center / research institution | Research-heavy oncology organization with high interest in trials, diagnostics, and systems | dana-farber.org | Research Director, Clinical Trials Manager, Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| Johns Hopkins Medicine | Academic medical center | Influential buyer for clinical research, oncology programs, and enterprise healthcare solutions | hopkinsmedicine.org | Vice Chair Oncology, Procurement Director, IT Strategy Lead | Strong Market Fit, Attendance Not Confirmed |
| City of Hope | Cancer research and treatment center | Oncology-focused institution with purchasing needs in research, care delivery, and tech | cityofhope.org | Oncology Program Director, Research Operations Lead, Sourcing Manager | Strong Market Fit, Attendance Not Confirmed |
| Kaiser Permanente | Integrated health system / payer-provider | Decision-maker environment for care pathways, utilization, analytics, and sourcing | kp.org | Medical Director Oncology, Supply Chain Manager, Health IT Director | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Pharmaceutical company | Oncology commercialization, medical affairs, evidence generation, and congress engagement | pfizer.com | Medical Affairs Director, Oncology Marketing Director, Congress Manager | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Pharmaceutical company | Major oncology stakeholder for education, trial data, and provider engagement | novartis.com | Field Medical Lead, Oncology Business Director, Global Congress Lead | Strong Market Fit, Attendance Not Confirmed |
| Merck & Co., Inc. | Pharmaceutical company | Oncology stakeholder for medical affairs, access, and event-based commercial engagement | merck.com | Director Medical Affairs, Oncology Commercial Lead, Congress Strategy Manager | Strong Market Fit, Attendance Not Confirmed |
| Bristol Myers Squibb | Pharmaceutical company | High oncology relevance for clinicians, evidence teams, and commercial functions | bms.com | Medical Director, Oncology Marketing, External Affairs Lead | Strong Market Fit, Attendance Not Confirmed |
| American Cancer Society | Nonprofit / advocacy organization | Policy, education, patient support, and partnership stakeholder | cancer.org | Program Director, Partnerships Manager, Government Affairs Lead | Strong Market Fit, Attendance Not Confirmed |
| National Cancer Institute | Government / research agency | Public-sector research and funding stakeholder for oncology programs and evidence generation | cancer.gov | Program Officer, Grants Manager, Research Director | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Chief Clinical Officer | Clinical leadership | C-level | Drives enterprise clinical adoption and strategic vendor decisions |
| 2 | Vice President, Oncology / Cancer Services Director | Oncology operations | VP / Director | Owns program-level priorities, partnerships, and service evaluation |
| 3 | Chief Procurement Officer / Procurement Director | Procurement | Executive / Director | Key decision-maker for purchasing, contracting, and vendor selection |
| 4 | Strategic Sourcing Manager / Category Manager | Supply chain / procurement | Manager / Senior Manager | Evaluates suppliers, pricing, and contracting for clinical and service categories |
| 5 | Director of Clinical Operations / Operations Director | Operations | Director | Responsible for workflow efficiency, staffing, and implementation of new services |
| 6 | Director, Health IT / CIO / CTO | Information technology | Executive / Director | Approves digital health, analytics, interoperability, and cybersecurity solutions |
| 7 | Clinical Trials Manager / Research Operations Director | Research / clinical trials | Manager / Director | Controls trial operations, site services, and research enablement purchasing |
| 8 | Medical Affairs Director / Field Medical Lead | Medical affairs | Director / Senior Manager | Critical for scientific exchange, congress strategy, and evidence-based engagement |
| 9 | Market Access / HEOR Director | Market access | Director / VP | Evaluates value, reimbursement, outcomes, and payer evidence needs |
| 10 | Partnerships Director / Business Development Director | Commercial / partnerships | Director / VP | Looks for collaborations, sponsorships, services, and strategic alliances |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Primary attendee base includes hospitals, cancer centers, and health systems | Clinical service, procurement, and IT targeting |
| 2 | Pharmaceuticals | Major oncology manufacturers attend for medical and commercial engagement | Medical affairs, congress, and market access outreach |
| 3 | Biotechnology | Biotech companies use ASCO for pipeline visibility and partner discovery | BD, partnering, clinical development, and investor relations |
| 4 | Medical Devices | Diagnostics, treatment devices, and clinical workflow tools are highly relevant | Product, procurement, and clinical evaluation targeting |
| 5 | Medical Practice | Oncology practices and physician groups are a practical buyer segment | Practice management, reimbursement, and clinical support solutions |
| 6 | Information Technology & Services | Digital health, analytics, and integration vendors support oncology operations | IT, data, interoperability, and cybersecurity outreach |
| 7 | Research | Clinical and translational research is central to the meeting | Trial operations, research tools, and evidence-generation services |
| 8 | Government Administration | Public-sector researchers and health agencies are relevant oncology stakeholders | Public health, policy, grants, and program outreach |
| 9 | Government Relations | Useful for advocacy, reimbursement, and policy-focused stakeholder engagement | Policy, advocacy, and external affairs targeting |
| 10 | Market Research | Commercial insights and evidence generation are key event themes | Insights, data, and advisory services |
| 11 | Management Consulting | Consultants support strategy, commercialization, and healthcare transformation | Advisory and transformation services outreach |
| 12 | Financial Services | Relevant to healthcare investment, reimbursement, and commercialization stakeholders | Investment, financing, and payer-related outreach |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Unconfirmed | Organizer website text provided did not include an attendance figure | Use only after organizer confirmation or official registration data |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No official exhibitor count provided in the supplied source | Prior-year or current-year directory would be required for verification |
| Buyer count | Not publicly confirmed | Unconfirmed | No official buyer-matching statistics supplied | Buyer volumes are typically inferred from attendee mix, not published totals |
| Speaker count | Not publicly confirmed | Unconfirmed | No agenda/speaker count included in the provided source excerpt | Could be verified from official agenda or abstract program |
| Sponsor count | Not publicly confirmed | Unconfirmed | Not present in supplied source text | Use official sponsor directory if available |
| Historical attendance | Not used here | Not verified in supplied source | Current prompt provides no verified historical attendance figure | Recommend confirming with official annual meeting registration or media kit |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical education | Guideline updates, treatment knowledge, CME/CE support | Sponsor sessions, workshops, medical education outreach | Medical education, content services, congress support |
| Clinical trials | Trial execution, site support, patient recruitment | Meet research leaders and operations teams | CRO services, eClinical platforms, site enablement |
| Diagnostics and pathology | Testing accuracy, throughput, informatics, automation | Target lab and precision medicine stakeholders | Diagnostic platforms, lab automation, LIS integration |
| Health IT / data | Interoperability, analytics, AI, workflow efficiency | Executive and IT stakeholder meetings | Data platforms, AI tools, EHR integration, cybersecurity |
| Market access / reimbursement | Value, outcomes, payer access, coding and coverage | Engage payer-facing and commercial teams | HEOR, RWE, access strategy, pricing support |
| Partnerships and commercialization | BD relationships, co-development, outreach | Meet pharma, biotech, and institutional leaders | Partnering services, consulting, communications |
| Procurement and operations | Vendor selection, cost control, implementation | Identify buying committees within health systems | SaaS, managed services, clinical supply chain solutions |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The meeting draws oncology decision-makers, procurement influences, and life sciences commercial teams. |
| Decision-maker availability | High | Likely strong presence of directors, VPs, and senior clinical and commercial leaders. |
| Data collection potential | High | Excellent for attendee intelligence, speaker profiling, and account mapping, though current-year public lists may be limited. |
| Apollo targeting potential | Very High | Strong industry and title fit across healthcare, pharma, biotech, IT, and procurement functions. |
| Geographic targeting potential | High | Chicago creates strong domestic accessibility and international draw for oncology stakeholders. |
| Best outreach approach | Account-based outreach | Target specific cancer centers, pharma teams, research organizations, and health systems with role-specific messaging. |
| Overall lead quality | Very High | One of the strongest healthcare-conference environments for buyer discovery and high-value B2B prospecting. |
| Best use case | Lead generation, attendee profiling, exhibitor targeting, and enterprise account mapping | Most useful for clinical solutions, pharma services, diagnostics, data platforms, and healthcare consulting. |
| Limitations / risks | Public attendee lists may be limited | Without a current official exhibitor/speaker directory, buyer lists should be treated as prospecting targets rather than confirmed participants. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Biotechnology; Medical Devices; Information Technology & Services; Research; Government Administration; Medical Practice; Market Research; Financial Services | Align account list with oncology buyers, commercial stakeholders, and healthcare decision-makers |
| Departments | Procurement, Supply Chain, Clinical Operations, IT, Research, Medical Affairs, Market Access, Business Development, Partnerships, Commercial | Reach the functions most likely to evaluate vendors, services, and partnerships |
| Seniority | Manager, Senior Manager, Director, VP, C-level | Prioritize decision-makers and committee influencers |
| Job titles | Chief Medical Officer, VP Oncology, Procurement Director, Strategic Sourcing Manager, Clinical Operations Director, CIO, CTO, Research Director, Medical Affairs Director, Market Access Director, Partnerships Director | Capture both clinical and commercial buyer roles relevant to the event |
| Geography | United States; Canada; United Kingdom; Germany; France; Switzerland; Netherlands; Japan; South Korea; Singapore | Reflect ASCO’s strong domestic and international oncology reach |
| Employee size | 200-1,000; 1,001-5,000; 5,001-10,000; 10,000+ | Capture health systems, pharma, biotech, and large research institutions |
| Keywords | oncology, cancer center, clinical trials, medical affairs, market access, precision medicine, diagnostics, pathology, health IT, RWE, HEOR, procurement | Improve relevance for event-based prospecting and account filtering |
| Company type | Public companies, enterprise healthcare systems, academic medical centers, nonprofit hospitals, research institutions | Focus on organizations with buying committees and multi-stakeholder decisions |
| Revenue range | $50M+ where applicable; prioritize enterprise accounts | Targets larger institutions most likely to attend or influence purchasing |
Suggested Apollo Search Logic: (oncology OR cancer OR “medical affairs” OR “clinical operations” OR “market access” OR “procurement” OR “strategic sourcing” OR “research operations”) AND (Director OR VP OR Manager OR “Chief” OR Head) AND (hospital OR health system OR pharma OR biotech OR medical device OR research)
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| American Society of Clinical Oncology (ASCO) | Official organizer website | Organizer identity, oncology focus, and official website context provided in the source excerpt | High |
| User-provided event details | Event briefing | Event title, date range, city, and country used for the report | Medium |
| ASCO About page | Official organizer reference | Organizational context and medical society identity | High |
| ASCO Education pages | Official organizer education content | Validated that ASCO is centered on oncology education and professional development | High |
| ASCO News / announcements | Official organizer updates | Used as a verification path for event-related announcements and meeting context | High |
| ASCO Quality Care content | Official thematic content | Supports oncology quality, clinical practice, and evidence-based meeting relevance | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to ASCO Annual Meeting — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds